Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lázaro Manuel Filgueira"'
Autor:
Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Carlos Herrera, Leniel Manso, Elibet Chávez, Armando Caballero, Carlos Hidalgo, Geydi Lorenzo, Meylan Cepeda, Carmen Valenzuela, Mayra Ramos, Kalet León, Zaima Mazorra, Tania Crombet
Publikováno v:
Immunity & Ageing, Vol 17, Iss 1, Pp 1-8 (2020)
Abstract Background Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the world has been placed. In Cuba, the first case of COVID-19 was reported on March 11. Elderly with multiple comorbidities have been the most r
Externí odkaz:
https://doaj.org/article/cc6578d157ba40c8873664470da11d33
Autor:
Yayquier Díaz Morales, Carlos Jorge Hidalgo Mesa, Ania Cecilia Reyes Roque, Lázaro Manuel Filgueira Morilla, Yolanda Beatriz Tamayo Díaz, Yaumara Aguilera Calzadilla
Publikováno v:
Edumecentro, Vol 12, Iss 3, Pp 8-24 (2020)
Fundamento: Cuba ha desplegado una estrategia nacional para la prevención y control contra la COVID-19; entre sus elementos se destaca la capacitación a profesionales y otros trabajadores del sector de la salud. Objetivo: mostrar el diseño y puest
Externí odkaz:
https://doaj.org/article/76f7451404d3449fbc0502388dd115a9
Autor:
Kalet León, Danay Saavedra, Armando Caballero, Jorge Alain Caballero, Zaima Mazorra, Carlos Figueredo, Ana Laura Añe-Kouri, Naivy Sánchez, Carlos Herrera, Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Mayra Ramos, Geidy Lorenzo, Jorge Berrio, Meylan Cepeda, Orlando Adolfo Lovelle, Tania Crombet
Publikováno v:
Immunotherapy
In COVID-19, the inflammatory cytokine-release syndrome is associated with the progression of the disease. Itolizumab is a monoclonal antibody that recognizes human CD6 expressed in activated T cells. The antibody has shown to be safe and efficacious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6225684e2389cf8de5c2ffe1d3bad65e
https://doi.org/10.2217/imt-2020-0235
https://doi.org/10.2217/imt-2020-0235
Autor:
Zaima Mazorra, Kalet León, Lázaro Manuel Filgueira, Mayra Ramos, Danay Saavedra, Armando Caballero, Julio Betancourt, Naivy Sánchez, Carmen Valenzuela, Tania Crombet, Meylan Cepeda, C. Hidalgo, Geydi Lorenzo, Ana Laura Añé-Kourí, Carlos Herrera, Elibet Chávez, Leniel Manso
Publikováno v:
Immunity & Ageing, Vol 17, Iss 1, Pp 1-8 (2020)
Immunity & Ageing : I & A
Immunity & Ageing : I & A
Background Since the COVID-19 outbreak an unprecedented challenge for healthcare systems around the world has been placed. In Cuba, the first case of COVID-19 was reported on March 11. Elderly with multiple comorbidities have been the most risky popu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90749d2b5633116faa4c060fc927da7e
http://link.springer.com/article/10.1186/s12979-020-00207-8
http://link.springer.com/article/10.1186/s12979-020-00207-8
Autor:
Alejandro Martínez, Lázaro Manuel Filgueira, Ulises Castillo, Danay Saavedra, Elio Meriño, Mayra Ramos, C. Hidalgo, Alberto Ramírez, Geydi Lorenzo, Julio Betancourt, Carmen Valenzuela, Patricia Lorenzo, Yanelda García, Lilia M Ortega, Henrry Diaz, Meylan Cepeda, Maylén Arencibia, Milagros Domecq, Lizet Sánchez, Tania Crombet, Zaima Mazorra, Daymys Estevez, Alberto Escalona, Rolando E Despaigne, Kalet León, Naivy Sánchez, Leticia Cabrera, Armando Caballero
Publikováno v:
Clinical & Translational Immunology
Objectives COVID‐19 can lead to a hyperinflammatory state. CD6 is a glycoprotein expressed on mature T lymphocytes which is a crucial regulator of the T‐cell activation. Itolizumab is a humanised antibody targeting CD6. Nonclinical and clinical d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9483cd7804b251be1212932961b9ee4e
https://doi.org/10.1002/cti2.1218
https://doi.org/10.1002/cti2.1218